Global Poliovirus Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Poliovirus Vaccine market size was valued at USD 730.3 million in 2023 and is forecast to a readjusted size of USD 974.8 million by 2030 with a CAGR of 4.2% during review period.
Polio vaccines are vaccines used to prevent poliomyelitis (polio).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Poliovirus Vaccine industry chain, the market status of Public (Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)), Private (Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poliovirus Vaccine.
Regionally, the report analyzes the Poliovirus Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poliovirus Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poliovirus Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poliovirus Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poliovirus Vaccine market.
Regional Analysis: The report involves examining the Poliovirus Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poliovirus Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poliovirus Vaccine:
Company Analysis: Report covers individual Poliovirus Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poliovirus Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public, Private).
Technology Analysis: Report covers specific technologies relevant to Poliovirus Vaccine. It assesses the current state, advancements, and potential future developments in Poliovirus Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poliovirus Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poliovirus Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Poliovirus Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poliovirus Vaccine, with price, sales, revenue and global market share of Poliovirus Vaccine from 2019 to 2024.
Chapter 3, the Poliovirus Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliovirus Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poliovirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poliovirus Vaccine.
Chapter 14 and 15, to describe Poliovirus Vaccine sales channel, distributors, customers, research findings and conclusion.
Polio vaccines are vaccines used to prevent poliomyelitis (polio).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Poliovirus Vaccine industry chain, the market status of Public (Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)), Private (Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Poliovirus Vaccine.
Regionally, the report analyzes the Poliovirus Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Poliovirus Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Poliovirus Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Poliovirus Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Poliovirus Vaccine market.
Regional Analysis: The report involves examining the Poliovirus Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Poliovirus Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Poliovirus Vaccine:
Company Analysis: Report covers individual Poliovirus Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Poliovirus Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public, Private).
Technology Analysis: Report covers specific technologies relevant to Poliovirus Vaccine. It assesses the current state, advancements, and potential future developments in Poliovirus Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Poliovirus Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Poliovirus Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Public
- Private
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Poliovirus Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Poliovirus Vaccine, with price, sales, revenue and global market share of Poliovirus Vaccine from 2019 to 2024.
Chapter 3, the Poliovirus Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Poliovirus Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Poliovirus Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Poliovirus Vaccine.
Chapter 14 and 15, to describe Poliovirus Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Poliovirus Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Poliovirus Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Inactivated Polio Vaccine (IPV)
1.3.3 Oral Polio Vaccine (OPV)
1.4 Market Analysis by Application
1.4.1 Overview: Global Poliovirus Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Public
1.4.3 Private
1.5 Global Poliovirus Vaccine Market Size & Forecast
1.5.1 Global Poliovirus Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Poliovirus Vaccine Sales Quantity (2019-2030)
1.5.3 Global Poliovirus Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Poliovirus Vaccine Product and Services
2.1.4 Sanofi Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Poliovirus Vaccine Product and Services
2.2.4 GSK Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Poliovirus Vaccine Product and Services
2.3.4 Bibcol Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bibcol Recent Developments/Updates
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Poliovirus Vaccine Product and Services
2.4.4 Serum Institute Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Serum Institute Recent Developments/Updates
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Poliovirus Vaccine Product and Services
2.5.4 Tiantan Biological Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Tiantan Biological Recent Developments/Updates
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Poliovirus Vaccine Product and Services
2.6.4 IMBCA Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 IMBCA Recent Developments/Updates
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Poliovirus Vaccine Product and Services
2.7.4 Panacea Biotec Ltd Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Panacea Biotec Ltd Recent Developments/Updates
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Poliovirus Vaccine Product and Services
2.8.4 Bio-Med Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio-Med Recent Developments/Updates
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POLIOVIRUS VACCINE BY MANUFACTURER
3.1 Global Poliovirus Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Poliovirus Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Poliovirus Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Poliovirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Poliovirus Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Poliovirus Vaccine Manufacturer Market Share in 2023
3.5 Poliovirus Vaccine Market: Overall Company Footprint Analysis
3.5.1 Poliovirus Vaccine Market: Region Footprint
3.5.2 Poliovirus Vaccine Market: Company Product Type Footprint
3.5.3 Poliovirus Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Poliovirus Vaccine Market Size by Region
4.1.1 Global Poliovirus Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Poliovirus Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Poliovirus Vaccine Average Price by Region (2019-2030)
4.2 North America Poliovirus Vaccine Consumption Value (2019-2030)
4.3 Europe Poliovirus Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Poliovirus Vaccine Consumption Value (2019-2030)
4.5 South America Poliovirus Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Poliovirus Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Poliovirus Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Poliovirus Vaccine Consumption Value by Type (2019-2030)
5.3 Global Poliovirus Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Poliovirus Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Poliovirus Vaccine Consumption Value by Application (2019-2030)
6.3 Global Poliovirus Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Poliovirus Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Poliovirus Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Poliovirus Vaccine Market Size by Country
7.3.1 North America Poliovirus Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Poliovirus Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Poliovirus Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Poliovirus Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Poliovirus Vaccine Market Size by Country
8.3.1 Europe Poliovirus Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Poliovirus Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Poliovirus Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Poliovirus Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Poliovirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Poliovirus Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Poliovirus Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Poliovirus Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Poliovirus Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Poliovirus Vaccine Market Size by Country
10.3.1 South America Poliovirus Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Poliovirus Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Poliovirus Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Poliovirus Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Poliovirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Poliovirus Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Poliovirus Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Poliovirus Vaccine Market Drivers
12.2 Poliovirus Vaccine Market Restraints
12.3 Poliovirus Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Poliovirus Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Poliovirus Vaccine
13.3 Poliovirus Vaccine Production Process
13.4 Poliovirus Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Poliovirus Vaccine Typical Distributors
14.3 Poliovirus Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Poliovirus Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Poliovirus Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Inactivated Polio Vaccine (IPV)
1.3.3 Oral Polio Vaccine (OPV)
1.4 Market Analysis by Application
1.4.1 Overview: Global Poliovirus Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Public
1.4.3 Private
1.5 Global Poliovirus Vaccine Market Size & Forecast
1.5.1 Global Poliovirus Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Poliovirus Vaccine Sales Quantity (2019-2030)
1.5.3 Global Poliovirus Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Poliovirus Vaccine Product and Services
2.1.4 Sanofi Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Poliovirus Vaccine Product and Services
2.2.4 GSK Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GSK Recent Developments/Updates
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Poliovirus Vaccine Product and Services
2.3.4 Bibcol Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bibcol Recent Developments/Updates
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Poliovirus Vaccine Product and Services
2.4.4 Serum Institute Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Serum Institute Recent Developments/Updates
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Poliovirus Vaccine Product and Services
2.5.4 Tiantan Biological Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Tiantan Biological Recent Developments/Updates
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Poliovirus Vaccine Product and Services
2.6.4 IMBCA Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 IMBCA Recent Developments/Updates
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Poliovirus Vaccine Product and Services
2.7.4 Panacea Biotec Ltd Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Panacea Biotec Ltd Recent Developments/Updates
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Poliovirus Vaccine Product and Services
2.8.4 Bio-Med Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio-Med Recent Developments/Updates
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: POLIOVIRUS VACCINE BY MANUFACTURER
3.1 Global Poliovirus Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Poliovirus Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Poliovirus Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Poliovirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Poliovirus Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Poliovirus Vaccine Manufacturer Market Share in 2023
3.5 Poliovirus Vaccine Market: Overall Company Footprint Analysis
3.5.1 Poliovirus Vaccine Market: Region Footprint
3.5.2 Poliovirus Vaccine Market: Company Product Type Footprint
3.5.3 Poliovirus Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Poliovirus Vaccine Market Size by Region
4.1.1 Global Poliovirus Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Poliovirus Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Poliovirus Vaccine Average Price by Region (2019-2030)
4.2 North America Poliovirus Vaccine Consumption Value (2019-2030)
4.3 Europe Poliovirus Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Poliovirus Vaccine Consumption Value (2019-2030)
4.5 South America Poliovirus Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Poliovirus Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Poliovirus Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Poliovirus Vaccine Consumption Value by Type (2019-2030)
5.3 Global Poliovirus Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Poliovirus Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Poliovirus Vaccine Consumption Value by Application (2019-2030)
6.3 Global Poliovirus Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Poliovirus Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Poliovirus Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Poliovirus Vaccine Market Size by Country
7.3.1 North America Poliovirus Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Poliovirus Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Poliovirus Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Poliovirus Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Poliovirus Vaccine Market Size by Country
8.3.1 Europe Poliovirus Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Poliovirus Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Poliovirus Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Poliovirus Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Poliovirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Poliovirus Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Poliovirus Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Poliovirus Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Poliovirus Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Poliovirus Vaccine Market Size by Country
10.3.1 South America Poliovirus Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Poliovirus Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Poliovirus Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Poliovirus Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Poliovirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Poliovirus Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Poliovirus Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Poliovirus Vaccine Market Drivers
12.2 Poliovirus Vaccine Market Restraints
12.3 Poliovirus Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Poliovirus Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Poliovirus Vaccine
13.3 Poliovirus Vaccine Production Process
13.4 Poliovirus Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Poliovirus Vaccine Typical Distributors
14.3 Poliovirus Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Poliovirus Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Poliovirus Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Poliovirus Vaccine Product and Services
Table 6. Sanofi Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Poliovirus Vaccine Product and Services
Table 11. GSK Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. Bibcol Basic Information, Manufacturing Base and Competitors
Table 14. Bibcol Major Business
Table 15. Bibcol Poliovirus Vaccine Product and Services
Table 16. Bibcol Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bibcol Recent Developments/Updates
Table 18. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 19. Serum Institute Major Business
Table 20. Serum Institute Poliovirus Vaccine Product and Services
Table 21. Serum Institute Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Serum Institute Recent Developments/Updates
Table 23. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 24. Tiantan Biological Major Business
Table 25. Tiantan Biological Poliovirus Vaccine Product and Services
Table 26. Tiantan Biological Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Tiantan Biological Recent Developments/Updates
Table 28. IMBCA Basic Information, Manufacturing Base and Competitors
Table 29. IMBCA Major Business
Table 30. IMBCA Poliovirus Vaccine Product and Services
Table 31. IMBCA Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. IMBCA Recent Developments/Updates
Table 33. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Panacea Biotec Ltd Major Business
Table 35. Panacea Biotec Ltd Poliovirus Vaccine Product and Services
Table 36. Panacea Biotec Ltd Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Panacea Biotec Ltd Recent Developments/Updates
Table 38. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Med Major Business
Table 40. Bio-Med Poliovirus Vaccine Product and Services
Table 41. Bio-Med Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bio-Med Recent Developments/Updates
Table 43. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Halfkin Bio-Pharmaceuticals Major Business
Table 45. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
Table 46. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 48. Global Poliovirus Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Poliovirus Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Poliovirus Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Poliovirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Poliovirus Vaccine Production Site of Key Manufacturer
Table 53. Poliovirus Vaccine Market: Company Product Type Footprint
Table 54. Poliovirus Vaccine Market: Company Product Application Footprint
Table 55. Poliovirus Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Poliovirus Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Poliovirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Poliovirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Poliovirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Poliovirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Poliovirus Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Poliovirus Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Poliovirus Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Poliovirus Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Poliovirus Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Poliovirus Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Poliovirus Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Poliovirus Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Poliovirus Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Poliovirus Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Poliovirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Poliovirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Poliovirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Poliovirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Poliovirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Poliovirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Poliovirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Poliovirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Poliovirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Poliovirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Poliovirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Poliovirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Poliovirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Poliovirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Poliovirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Poliovirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Poliovirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Poliovirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Poliovirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Poliovirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Poliovirus Vaccine Raw Material
Table 116. Key Manufacturers of Poliovirus Vaccine Raw Materials
Table 117. Poliovirus Vaccine Typical Distributors
Table 118. Poliovirus Vaccine Typical Customers
Table 1. Global Poliovirus Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Poliovirus Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Poliovirus Vaccine Product and Services
Table 6. Sanofi Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Poliovirus Vaccine Product and Services
Table 11. GSK Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GSK Recent Developments/Updates
Table 13. Bibcol Basic Information, Manufacturing Base and Competitors
Table 14. Bibcol Major Business
Table 15. Bibcol Poliovirus Vaccine Product and Services
Table 16. Bibcol Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bibcol Recent Developments/Updates
Table 18. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 19. Serum Institute Major Business
Table 20. Serum Institute Poliovirus Vaccine Product and Services
Table 21. Serum Institute Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Serum Institute Recent Developments/Updates
Table 23. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 24. Tiantan Biological Major Business
Table 25. Tiantan Biological Poliovirus Vaccine Product and Services
Table 26. Tiantan Biological Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Tiantan Biological Recent Developments/Updates
Table 28. IMBCA Basic Information, Manufacturing Base and Competitors
Table 29. IMBCA Major Business
Table 30. IMBCA Poliovirus Vaccine Product and Services
Table 31. IMBCA Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. IMBCA Recent Developments/Updates
Table 33. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Panacea Biotec Ltd Major Business
Table 35. Panacea Biotec Ltd Poliovirus Vaccine Product and Services
Table 36. Panacea Biotec Ltd Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Panacea Biotec Ltd Recent Developments/Updates
Table 38. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Med Major Business
Table 40. Bio-Med Poliovirus Vaccine Product and Services
Table 41. Bio-Med Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bio-Med Recent Developments/Updates
Table 43. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Halfkin Bio-Pharmaceuticals Major Business
Table 45. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
Table 46. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 48. Global Poliovirus Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Poliovirus Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Poliovirus Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Poliovirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Poliovirus Vaccine Production Site of Key Manufacturer
Table 53. Poliovirus Vaccine Market: Company Product Type Footprint
Table 54. Poliovirus Vaccine Market: Company Product Application Footprint
Table 55. Poliovirus Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Poliovirus Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Poliovirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Poliovirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Poliovirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Poliovirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Poliovirus Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Poliovirus Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Poliovirus Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Poliovirus Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Poliovirus Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Poliovirus Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Poliovirus Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Poliovirus Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Poliovirus Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Poliovirus Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Poliovirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Poliovirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Poliovirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Poliovirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Poliovirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Poliovirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Poliovirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Poliovirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Poliovirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Poliovirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Poliovirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Poliovirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Poliovirus Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Poliovirus Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Poliovirus Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Poliovirus Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Poliovirus Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Poliovirus Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Poliovirus Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Poliovirus Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Poliovirus Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Poliovirus Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Poliovirus Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Poliovirus Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Poliovirus Vaccine Raw Material
Table 116. Key Manufacturers of Poliovirus Vaccine Raw Materials
Table 117. Poliovirus Vaccine Typical Distributors
Table 118. Poliovirus Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Poliovirus Vaccine Picture
Figure 2. Global Poliovirus Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Poliovirus Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Inactivated Polio Vaccine (IPV) Examples
Figure 5. Oral Polio Vaccine (OPV) Examples
Figure 6. Global Poliovirus Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Poliovirus Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Public Examples
Figure 9. Private Examples
Figure 10. Global Poliovirus Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Poliovirus Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Poliovirus Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Poliovirus Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Poliovirus Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Poliovirus Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Poliovirus Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Poliovirus Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Poliovirus Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Poliovirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Poliovirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Poliovirus Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Poliovirus Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Poliovirus Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Poliovirus Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Poliovirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Poliovirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Poliovirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Poliovirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Poliovirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Poliovirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Poliovirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Poliovirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Poliovirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Poliovirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Poliovirus Vaccine Market Drivers
Figure 73. Poliovirus Vaccine Market Restraints
Figure 74. Poliovirus Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Poliovirus Vaccine in 2023
Figure 77. Manufacturing Process Analysis of Poliovirus Vaccine
Figure 78. Poliovirus Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Poliovirus Vaccine Picture
Figure 2. Global Poliovirus Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Poliovirus Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Inactivated Polio Vaccine (IPV) Examples
Figure 5. Oral Polio Vaccine (OPV) Examples
Figure 6. Global Poliovirus Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Poliovirus Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Public Examples
Figure 9. Private Examples
Figure 10. Global Poliovirus Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Poliovirus Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Poliovirus Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Poliovirus Vaccine Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Poliovirus Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Poliovirus Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Poliovirus Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Poliovirus Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Poliovirus Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Poliovirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Poliovirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Poliovirus Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Poliovirus Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Poliovirus Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Poliovirus Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Poliovirus Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Poliovirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Poliovirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Poliovirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Poliovirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Poliovirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Poliovirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Poliovirus Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Poliovirus Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Poliovirus Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Poliovirus Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Poliovirus Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Poliovirus Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Poliovirus Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Poliovirus Vaccine Market Drivers
Figure 73. Poliovirus Vaccine Market Restraints
Figure 74. Poliovirus Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Poliovirus Vaccine in 2023
Figure 77. Manufacturing Process Analysis of Poliovirus Vaccine
Figure 78. Poliovirus Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
